Omar Mousa, M.B.B.S., M.D.

I specialize in preventing, diagnosing and treating digestive tract and liver disorders. These mainly include conditions involving the liver, gallbladder, pancreas, esophagus, stomach, small intestine and colon, with a special focus on liver disease and liver transplantation.

I highly value the three shields of Mayo Clinic, as my clinical practice drives my passion for research and education.

I believe that providing the best care should be based on treating patients and family members with sensitivity and empathy, listening to patients and dedicating our efforts to meet the needs of the patient.

Education

• Jordan University of Science and Technology

Internship

• Arab Medical Center Hospital & Ministry of Health

Residency

• Internal Medicine, State University of New York Upstate Medical University

Fellowships

• Gastroenterology and Hepatology, Mayo Clinic School of Graduate Medical Education
• Transplant Hepatology, Mayo Clinic School of Graduate Medical Education

Certifications

• Gastroenterology, American Board of Internal Medicine
• Internal Medicine, American Board of Internal Medicine
• Transplant Hepatology, American Board of Internal Medicine

Memberships

• American Association for the Study of Liver Disease
• American College of Gastroenterology
• American College of Physicians
• American Gastroenterology Association
• Honor Society member and donor: Gold Humanism Honor Society (GHHS)

Academic Appointment

• Assistant Professor of Medicine, Mayo Clinic College of Medicine and Science

• Abnormal liver profile
• Acute liver failure
• Alcohol-related liver disease (including primary sclerosing cholangitis and primary biliary cholangitis)
• Autoimmune hepatitis
• Cholestatic liver disease
• Chronic viral hepatitis (hepatitis A to E)
• Cirrhosis, portal hypertension and complications of cirrhosis (including varices, portal vein thrombosis and ascites)
• Clinical research including clinical trials (hepatology and liver transplantation)
• Endoscopy and colonoscopy
• Fatty liver disease/Non-alcoholic steato hepatitis (NASH)
• General gastroenterology and digestive diseases
• GI bleeding
• Hemochromatosis, alpha-1 antitrypsin deficiency, Wilson's disease
• Hepatobiliary cancer and other liver masses
• Liver fibrosis assessment and liver biopsy
• Liver transplantation

• Evolving Role of Liver Transplantation in Elderly Recipients, December 2019
• Everolimus: Longer-Term CERTITUDE, December 2019
• Unique Phenotypic Characteristics and Clinical Course in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis: A Multicenter US Experience, October 2019
• Clinical outcomes of hepatitis C treatment before and after kidney transplantation and its impact on time to transplant: A multicenter study, October 2018
• Racial, Ethnic, and Age Disparities in Incidence and Survival of Intrahepatic Cholangiocarcinoma in the United States; 1995-2014, August 2018